Soichiro Saikawa

Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake

Kosuke Kaji, Norihisa Nishimura, Kenichiro Seki et al. · International Journal of Cancer · 2017 · 247 citations

Medicine, Oncology, Pharmacology +16

Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity

Kosuke Kaji, Hiroaki Takaya, Soichiro Saikawa et al. · World Journal of Gastroenterology · 2017 · 102 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis

Masanori Furukawa, Kei Moriya, Jiro Nakayama et al. · Hepatology Research · 2020 · 86 citations · Full text

Life Sciences, Microbiology, Pathology +17

von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C

Hiroaki Takaya, Hideto Kawaratani, Yuki Tsuji et al. · United European Gastroenterology Journal · 2018 · 48 citations · Full text

Medicine, Pathology, Carcinogenesis +16

Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein

Soichiro Saikawa, Kosuke Kaji, Norihisa Nishimura et al. · Cancer Letters · 2018 · 48 citations · Full text

Medicine, Cancer Biology, Oncology +17